X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cancer (6) 6
ovarian cancer (6) 6
colorectal cancer (5) 5
chemotherapy (4) 4
oncology (4) 4
resveratrol (4) 4
female (3) 3
humans (3) 3
prevention (3) 3
adcs (2) 2
aflatoxin (2) 2
antineoplastic agents - therapeutic use (2) 2
breast cancer (2) 2
cancer patients (2) 2
cancer research (2) 2
care and treatment (2) 2
chemoprevention (2) 2
fibers (2) 2
glucose metabolism (2) 2
hematology (2) 2
hiv infection (2) 2
index medicus (2) 2
internal medicine (2) 2
medicine & public health (2) 2
middle aged (2) 2
molecular biology (2) 2
mtor inhibitor (2) 2
mycotoxin (2) 2
nadcs (2) 2
nutritional agents (2) 2
ovarian neoplasms - drug therapy (2) 2
polyps (2) 2
renal-cell carcinoma (2) 2
research (2) 2
salvage therapy (2) 2
tamoxifen (2) 2
toxicity (2) 2
treatment outcome (2) 2
wheat bran (2) 2
abdominal desmoid tumors (1) 1
adjuvant chemotherapy (1) 1
adult (1) 1
aggressive fibromatosis (1) 1
alopecia - chemically induced (1) 1
amifostine (1) 1
analysis (1) 1
anemia - chemically induced (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
benzamides (1) 1
bisphosphonates (1) 1
bone metastasis (1) 1
brca1 (1) 1
brca2 mutations (1) 1
brcaness (1) 1
breast (1) 1
ca-125 (1) 1
cancer prevention (1) 1
carcinoma (1) 1
carriers (1) 1
case studies (1) 1
chemotherapy, adjuvant (1) 1
chronic cyclosporine nephrotoxicity (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
clavicle (1) 1
combination chemotherapy (1) 1
development and progression (1) 1
dna microarray (1) 1
double-blind method (1) 1
drug administration schedule (1) 1
drug metabolism (1) 1
endocrine system diseases (1) 1
enzyme inhibitors (1) 1
expression (1) 1
familial polyposis (1) 1
feasibility studies (1) 1
fibromatosis, aggressive - drug therapy (1) 1
fibromatosis, aggressive - pathology (1) 1
fibromatosis, aggressive - surgery (1) 1
founder effect mutations (1) 1
gene (1) 1
gene mutations (1) 1
gene profile (1) 1
genetic aspects (1) 1
genetic tests (1) 1
germline mutations of brca1 (1) 1
growth (1) 1
health aspects (1) 1
hematology, oncology and palliative medicine (1) 1
hypomagnesemia (1) 1
identification and classification (1) 1
imatinib mesylate (1) 1
improved survival (1) 1
kidney diseases - chemically induced (1) 1
kidney diseases - prevention & control (1) 1
kinases (1) 1
long-term survival (1) 1
magnesium (1) 1
magnesium - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hereditary Cancer in Clinical Practice, ISSN 1731-2302, 01/2016, Volume 14, Issue 1, p. 1
Background: The role of germline mutations in BRCA1 and BRCA2 genes in the risk of the development of ovarian cancer is clinically well established. BRCA1/2... 
Chemotherapy | Survival | Germline mutations of BRCA1 | Ovarian cancer | BRCA2 MUTATIONS | IMPROVED SURVIVAL | CARRIERS | BREAST | WOMEN | PROGNOSTIC-FACTOR | GENE | ONCOLOGY | PREDICT | BRCANESS | Enzyme inhibitors | Gene mutations | Patient outcomes | Drug metabolism | Development and progression | Genetic aspects | Identification and classification | Health aspects
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 6/2009, Volume 135, Issue 6, pp. 815 - 821
Journal Article
Wspólczesna Onkologia, ISSN 1428-2526, 03/2010, Volume 14, Issue 2, p. 72
  Ovarian cancer is the leading cause of mortality in women with gynaecological cancers. Cytoreductive surgery has been considered as a mainstay in manage­ment... 
Journal Article
Wspólczesna Onkologia, ISSN 1428-2526, 08/2005, Volume 9, Issue 7, p. 300
  Colorectal cancer appears to be a real challenge for modern oncology. The global morbidity and mortality represent 875 K new cases and 570 K deaths per... 
Journal Article
Wspólczesna Onkologia, ISSN 1428-2526, 01/2006, Volume 10, Issue 1, p. 34
  Prostate cancer continues to represent a major therapeutic challenge. There is still observed a large number of patients worldwide. This malignancy is mainly... 
Journal Article
Wspólczesna Onkologia, ISSN 1428-2526, 03/2006, Volume 10, Issue 3, p. 103
  A human population affected by colorectal cancer embraces residents of the West or others but with their style of life accepted. The global morbidity and... 
Journal Article
Reference
2016, ISBN 1630670359
Nonalcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), insulin resistance (IR), hepatic steatosis (HS), nonalcoholic steatohepatitis (NASH), c-jun... 
renal-cell carcinoma | mTOR inhibitor | Breast cancer | tamoxifen
Book Chapter
12/2015, ISBN 9781630670368
Nonalcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), insulin resistance (IR), hepatic steatosis (HS), nonalcoholic steatohepatitis (NASH), c-jun... 
MTOR inhibitor | Breast cancer | Renal-cell carcinoma | Tamoxifen
Book Chapter
06/2015, ISBN 9780128007693, Volume 1
Zoonotic infection with simian immunodeficiency viruses is an initial step for human immunodeficiency virus (HIV) infection afflicting the human population... 
Mycotoxin | NADCs | ADCs | HIV infection | Aflatoxin | Cancer
Book Chapter
2015, ISBN 9780128007693
Zoonotic infection with simian immunodeficiency viruses is an initial step for human immunodeficiency virus (HIV) infection afflicting the human population... 
mycotoxin | NADCs | cancer | aflatoxin | HIV infection | ADCs
Book Chapter
2014, ISBN 9780124017160
Colorectal cancer is diagnosed in 1 million humans each year, and more than half a million people die from this disease annually, equivalent to approximately... 
Prevention | Colorectal cancer | Polyps | Fibers | Wheat bran
Book Chapter
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.